Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Thentia secures $38M to drive global expansion, innovation in regulatory technology and artificial intelligence

Published

on

thentia-secures-$38m-to-drive-global-expansion,-innovation-in-regulatory-technology-and-artificial-intelligence

First Ascent Ventures, Spring Mountain Capital, BDC Capital and Espresso Capital lead Thentia’s latest $38M Series B extension round, supporting the company’s continued growth.

OKLAHOMA CITY, Okla., Jan. 26, 2024 /PRNewswire/ — Thentia, a leading innovator in regulatory technology, announced today that it has closed a US$38 million Series B extension round. The fundraise, led by existing investors including First Ascent Ventures, Spring Mountain Capital, BDC Capital, and Espresso Capital, reflects a continued commitment to Thentia’s vision. The funds will be strategically utilized to scale operations, propel accelerated growth, invest in artificial intelligence, and enhance Thentia’s ability to meet the evolving needs of its rapidly expanding global client base.

“We are thrilled to continue our support for Thentia with this latest investment. The remarkable strides they’ve made, coupled with their unwavering dedication to innovation in the government technology space, solidify our confidence in their inevitable global prominence,” says Richard Black, Co-Founder and Managing Partner, First Ascent Ventures. “As existing investors, we remain excited about the impressive momentum they have gained, and we look forward to witnessing their continued success in shaping the future of government technology and regulation,” Black adds.

“Thentia’s cutting-edge platform stands as a cornerstone for government agencies embarking on the journey of digital transformation. By seamlessly transitioning processes into the 21st century, Thentia empowers organizations to elevate user experiences for citizens while delivering indispensable data crucial for informed decision-making. These strides signify a pivotal shift in advancing government capabilities,” says Jamie Weston, Managing Director, Spring Mountain Capital.

“We’re pleased to continue our ongoing partnership with Thentia as it enters a new phase of rapid expansion and growth. The company’s cutting-edge platform delivers tremendous value to customers across North America and Europe by bringing innovation and efficiency to the regulatory industry,” says Will Hutchins, Managing Director, Espresso Capital.

“Thentia has brought together an exceptional group of leaders and subject matter experts who grasp the unique challenges facing regulators” says Mark Smith, Partner of BDC Capital’s Industrial, Clean and Energy Technology (ICE) Venture Fund, which has been an investor in the business since 2020. “Their differentiated expertise is what truly sets them apart and has enabled them to develop a platform that addresses key regulatory functions, and positions Thentia as a leader in the regulatory licensing category.”

Designed for regulators, by regulators, Thentia’s end-to-end SaaS ERP platform, Thentia Cloud, adeptly digitizes, streamlines, and consolidates all essential regulatory functions within a single and secure cloud-based environment. Empowering regulators with a comprehensive 360-degree view of all licensee activities, the platform facilitates a shift from suboptimal and inefficient processes to a modern, streamlined approach, elevating their ability to fulfill their paramount duty of safeguarding the public. Customers of the platform have demonstrated manifold improvements in their ability to regulate effectively and efficiently.

Trusted by millions of licensed professionals, businesses, and entities globally, Thentia has gained recognition from regulators worldwide for its unmatched blend of technological innovation and regulatory proficiency.

“We’re grateful for the steadfast support of our investors who have played a pivotal role in our journey. Together, we have not only built the regulatory platform of the future, but have also achieved remarkable success, becoming a leading force in enabling regulators to stay a step ahead with the rapidly evolving technology landscape,” says Julian Cardarelli, CEO, Thentia.

“Looking ahead in 2024, we are poised to unveil an array of innovations that promise to redefine the industry landscape. These transformative capabilities are not just enhancements; they are industry-altering advancements that will set a new standard for what is possible, forever changing the way we operate and leading us into a new era of excellence and innovation.”

As Thentia charts its course for continued growth, the company stands resolute in its dedication to excellence and the ongoing innovation of its platform that is committed to supporting regulators in their mission of public protection. Moving forward, Thentia will strategically allocate the recently secured funds to drive geographical expansion, unveil new cutting-edge features, and attract top-tier talent. This comprehensive strategy aims to elevate every aspect of its team, ultimately ensuring a world-class experience for its valued customers.

About Thentia

Thoughtfully built for regulators, by regulators, Thentia is driving regulatory transformation for hundreds of regulators and regulatory agencies worldwide with a platform that handles all key department functions including licensing, investigations, enforcement, fitness to practise, quality assurance, scope of practise, continuing education, board management, data analysis, and more. Thentia Cloud empowers regulators to transcend the constraints of legacy processes, custom-built solutions, and a web of disparate applications with a single unified 360-degree platform, setting new standards in efficiency and effectiveness.

Thentia Cloud is available on all major cloud providers, including Google Cloud, Amazon Web Services (AWS), IBM Cloud, and Microsoft Azure. For more information, visit thentia.com.

About First Ascent Ventures

Founded in 2015 by Richard Black and Tony van Marken, First Ascent Ventures invests in early-stage, emerging, and growth-oriented enterprise software companies in the information technology sector. The First Ascent Ventures team bring deep bench strength as operating executives and investors having built and invested in significant, global enterprise software companies.

About Spring Mountain Capital

Spring Mountain Capital is a New York-based investment management firm with $1.7 billion of assets under management that focuses on alternative asset investing. The SMC Growth equity team focuses on providing expansion capital to companies capitalizing on breakthrough innovations, paradigm shifts, or fundamental market or behavioral changes. SMC invests in two sectors of the U.S. economy undergoing the most change and with the highest growth potential: enterprise technology and healthcare companies. For more information, visit: smcgrowthcapital.com.

About BDC Capital

BDC Capital is the investment arm of BDC, Canada’s bank for entrepreneurs. With over $6 billion under management, BDC Capital serves as a strategic partner to the country’s most innovative firms. It offers businesses a full spectrum of capital, from seed investments to growth equity as well as ownership transition solutions, supporting Canadian entrepreneurs who have the ambition to stand out on the world stage. Visit bdc.ca/capital.

About Espresso Capital

Espresso Capital has been empowering fast-growing technology companies with innovative venture debt solutions since 2009. During this period, we’ve funded over 330 companies in the U.S., Canada, and the U.K., helping to accelerate growth, extend runway, and increase strategic flexibility with non-dilutive capital. Espresso is headquartered in Toronto, with offices in San Francisco, Chicago, and London. To learn more about how you can use venture debt to grow your business, visit espressocapital.com.

For media inquiries, please contact:

Kerri-Lynn Kilbey
Communications Manager
T: (437) 703-9412
E: [email protected]

Photo – https://mma.prnewswire.com/media/2327781/Thentia_Corporation_Thentia_secures__38M_to_drive_global_expansi.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/thentia-secures-38m-to-drive-global-expansion-innovation-in-regulatory-technology-and-artificial-intelligence-302045799.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending